In a recent prospective cohort study, the gain-of-function A1166C (rs5186) variant in the AGTR1 gene represented a strong predictor of incident NAFLD and related arterial hypertension [199]. This evidence concerns the gene AGTR1 and metabolic dysfunction-associated steatotic liver disease.